Home › Acute Myeloid Leukemia › Wisconsin › Milwaukee

Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Milwaukee, WI

Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Milwaukee. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Nagre-recruitPhase 2

Aurora Cancer Care-Milwaukee, Milwaukee
Aurora Saint Luke's Medical Center, Milwaukee
Medical College of Wisconsin, Milwaukee
at 12 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564390

Ivosidenib as Post-HSCT Maintenance for AML

Nagre-recruitPhase 2

Froedtert Hospital & the Medical College of Wisconsin, Milwaukee

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06707493

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Aurora Cancer Care-Milwaukee, Milwaukee
Aurora Saint Luke's Medical Center, Milwaukee
Aurora Sinai Medical Center, Milwaukee
at 9 pa

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Wisconsin, Milwaukee

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Medical College of Wisconsin, Milwaukee

Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Medical College of Wisconsin, Milwaukee

Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Nagre-recruitPhase 2

Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Nagre-recruitPhase 3

Children's Hospital of Wisconsin, Milwaukee

6 Months – 21 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT04293562

A Study of BGB-11417 in Participants With Myeloid Malignancies

Nagre-recruitPhase 1/2

Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT04771130

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3

Froedtert & Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Froedtert & Medical College Clinics, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Nagre-recruitPhase 1

Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06656494

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Wisconsin, Milwaukee

Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Nagre-recruitPhase 2/3

Froedtert & Medical College of Wisconsin, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1

Medical College of Wisconsin Cancer Center, Milwaukee

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Nagre-recruitPhase 1

Children's Wisconsin, Milwaukee

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT05317403

Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod

Iba pang pag-aaral sa Milwaukee

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.